Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,379Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 7112592

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206494

Patent Use Code : U-2508

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-07

Abbvie Company Banner

02

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 7112592

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206494

Patent Use Code : U-2244

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-07

Abbvie Company Banner

03

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 7112592

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206494

Patent Use Code : U-282

Delist Requested :

Patent Use Description : METHOD OF TREATING BAC...

Patent Expiration Date : 2026-01-07

Abbvie Company Banner

04

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 7112592

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206494

Patent Use Code : U-3818

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-07

Abbvie Company Banner

05

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 9284314

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-15

Abbvie Company Banner

06

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 7612087

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-12

Abbvie Company Banner

07

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 8471025

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-12

Abbvie Company Banner

08

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 8969566

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-15

Abbvie Company Banner

09

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 8835455

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-08

Abbvie Company Banner

10

arrow
Antibody Engineering
Not Confirmed

AVIBACTAM SODIUM; CEFTAZIDIME

US Patent Number : 9695122

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206494

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-15

Abbvie Company Banner